𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Disease progression in patients with mild-to-moderate Alzheimer's disease treated with galantamine: Results of a two-year open-label study

✍ Scribed by Gaudig, Maren; Richarz, Ute; Rettig, Klaus; Djelani, Miriam; Schauble, Barbara


Book ID
122691981
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
52 KB
Volume
8
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A multinational, randomised, 12-week stu
✍ Roy W. Jones; Hilkka Soininen; Klaus Hager; Dag Aarsland; Peter Passmore; Anita πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 180 KB πŸ‘ 2 views

## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati